Opinion|Videos|November 30, 2023
How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer
Author(s)Sara M. Tolaney, MD, MPH
HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Optune Pax for Locally Advanced Pancreatic Cancer
2
From Clinical Trials to CAR-T Cell Therapy: A Patient’s Journey With Myeloma
3
Expert Discusses FDA Approval of Chemo-Free Option for EGFR-Mutated Lung Cancer
4
Genomic Testing Guides Treatment for Patient With Lung Cancer
5